Certara Regulatory and Medical Writing business Acquired by Veristat | Healthcare M&A Deal

Veristat has acquired the Certara Regulatory and Medical Writing business, a healthcare services other business in the United States, for approximately $140 million. The acquired regulatory and medical writing capabilities support clinical documentation, regulatory submissions, and documentation services for healthcare and life sciences clients. Veristat acquisitions in healthcare M&A aim to expand end-to-end regulatory support and strengthen delivery capacity for global trials. This platform acquisition is backed by private equity, with the Certara Regulatory and Medical Writing business acquisition positioned as a scale-building addition within healthcare services other acquisition strategy.